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Introduction: Pharmacological neuroenhancement (PN) is a topic of increasing
importance and prevalence among students. However, there is a lack of differentiating
PN substances, according to their psychoactive effects. In particular, there is a lack
of data about PN by caffeinated drinks, even if coffee is a common and broadly used
Neuroenhancer because of its cognitively enhancing effects regarding wakefulness,
alertness and concentration.
Materials and Methods: A web-survey was developed for German students and
alumni about the non-medical use of caffeine for PN contained questions about coffee,
caffeinated drinks and energy drinks, caffeine pills and methylxanthine tea regarding
frequency and further contextual factors.
Results: Six hundred and eighty-three participants completed the survey. Nearly all
participants knew about PN (97.7%). 88.1% admitted using some over-the-counter
substances. For PN purposes, coffee was used by 72.9% followed by energy drinks
(68.2%) and cola drinks (62.4%). Methylxanthine containing tea was used for PN
purposes, too (black tea 52.3%, green tea 51.7%). 1.8% admitted using illegal
substances or prescription drugs, too.
Discussion: Using legal methylxanthine containing drinks for PN seems to be extremely
common with coffee and energy drinks being the preferred substances, while illegal
and prescription drugs are only minimally used. Further studies should investigate the
awareness of methylxanthine containing drinks as well as its character to be a flavoring
drink or a neuroenhancer.
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INTRODUCTION
The article “Poll results: Look who is doping” is one of the most cited articles in the field of
pharmacological neuroenhancement (PN) (1). In 2008, Nature ran this online poll among their
readers to study the frequency and reasons regarding the use of psychoactive substances to
enhance cognitive performance. Until today, this article can be considered as “conversation starter.”
However, meanwhile there are much more studies examining the phenomenon of using substances
to increase cognition deeper and much more systematic.
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The term “smart drugs” is used for this group of drugs, as well
as other synonyms e.g., brain doping, academic performance
enhancement, cognitive enhancement or pharmacological
neuroenhancement (PN). PN is mostly defined as the non-
medical use of divergent psychoactive substances to increase
vigilance, attention, concentration or memory by healthy
subjects (2–4).
The above mentioned poll assessed the use of
methylphenidate, modafinil and beta blockers for cognitive
enhancement. The authors demonstrate that 20% of the 1,400
participants had used at least one of the aforementioned
substances to improve their focus, concentration or memory
without medical need (1). Meanwhile there are several national
and international publications about the use of prescription as
well as illicit substances for PN. They show lifetime prevalence
rates of 1 up to 20% depending on the substances assessed, the
survey methods used and other factors (5–10). However, until
today there is a paucity of studies regarding legal over the counter
(OTC-) substances such as caffeine for PN and their contextual
factors. Although, caffeine—standing for the best well-known
representative of the chemical group of methylxanthines (such
as caffeine, theobromine, theophylline) (11)—has proved
pro-cognitive effects [e.g., (12–16)]. Methylxanthines are legal
alternative PN substances compared to prescription and illicit
substances (e.g., amphetamines, modafinil, etc.). Regarding this
comparison, methylxanthines are frequently preferred by several
students based on ethical, legal and medical reasons (17). Beyond
that, the use of coffee has to be considered as a cultural habit
with the well-known “side effect” of having wake promoting
properties—especially when being tired (11).
“Real” side effects such as jitteriness, sleeplessness,
stomachache etc. have to be considered when using
methylxanthine containing substances. Side effects are listed
inter alia in the so called “Arzneimittelfachinformation” of the
only caffeine containing tablet in Germany (Coffeinum R©). Of
course, these possible side effects can harm users but they can be
considered as “minor” side effects compared to the side effects
of amphetamines, methylphenidate or modafinil [e.g., (18)].
Nevertheless, when deciding to use a PN substance, students
make their individual decision regarding the choice of the type
of the PN substance in parts based on ethical aspects but mainly
dominated by medical and legal aspects (17).
Even if caffeinated substances epidemiologically seem to be
well-known for PN [e.g., (7, 19–21)], there is a paucity of
studies enabling a deeper understanding of this context. For
example, Forlini et al. showed that most students knew about the
possibility to use coffee, caffeinated drinks and caffeine tablets for
PN; in this study 56% indicated a past use of coffee and 41% a past
use of energy drinks for PN purposes (20). Franke et al. showed
similar results in 2011 (22). In sum, superficial aspects about
caffeine for PN have been studied while systematic data about the
use of methylxanthines combined with contextual factors for a
deeper understanding are missing.
An older survey on caffeine use in university students showed,
lifetime, past-year and past-month prevalence rates for the use
of coffee specifically for PN of 53.2, 8.5, and 6.3%, for the
use of energy drinks of 39, 10.7, and 6.3%, and for the use of
caffeine tablets of 10.5, 3.8, and 0.8% (22). Additionally, a survey
study among surgeons revealed lifetime, past-year, past-month,
and past-week prevalence rates for coffee specifically for PN of
66.8, 61.9, 56.9, and 50.5% (2). For energy drinks they found
prevalence rates of 24.2, 15.4, 9.9, and 6.1% and for caffeine
tablets of 12.6, 5.9, 4.7, and 3.8% (2). Both studies showed the
use in light of stress, pressure to perform and reduction of fatigue
(2, 22). However, these and other studies do not give deeper
insights in methylxanthine use for PN such as psychotropic and
side effects, the amount of used cups of coffee per day, product
names of energy drinks, etc.
The mechanism of action of methylxanthines has been
investigated in the past (11) and leads to states of increased
cognitive abilities (reduced fatigue, increased wakefulness,
concentration, shortened reaction time, etc.) (2, 23, 24).
Clinically, pro-cognitive effects of caffeine have been shown to
be comparable to effects of stimulants such as amphetamines:
Randomized controlled trials showed 600mg of caffeine to have
comparable clinical effects to 20mg of dextro amphetamine or
400mg of modafinil in healthy sleep-deprived subjects (at least
regarding the restoration of simple psychomotor performance
and objective alertness) (13–15). Beyond that, a comparison
between coffee and the so called “energy drinks”—having
additional ingredients such as taurine—showed that energy
drinks have stronger clinical effects regarding cognitive PN
domains than coffee (25).
Beyond coffee, methylxanthine containing tea and energy
drinks, there are caffeine pills containing different amounts
of caffeine. In Germany, Coffeinum R© is sold in specialized
pharmacy stores, each pill containing 200mg of caffeine. It is
approved for short time reduction of tiredness. This amount of
caffeine “per pill” is less than the amount of caffeine usually
found in a grande coffee in a coffee shop containing more or less
500–600mg of caffeine.
The character of caffeine has three different faces: (1)
coffee primarily as a flavoring beverage, (2) energy drinks
(and other beverages and foods) containing caffeine as a food
supplement, and (3) caffeine tablets that have to be regarded as
a drug/medication.
Summing up, caffeine in various routes of administration
seems to be a widespread PN drug. The present web-based study
was designed to improve the current database on knowledge
and prevalence rates by further contextual factors such as
differentiating methylxanthines, frequency and amount of use
and further factors such as effects, side effects as well as a
combination with other psychoactive substances.
Therefore, this preliminary study assessed a convenience
sample of students, alumni and associated people at a University
of Applied Sciences (UAS) in Mecklenburg-Vorpommern, a
federal German state, about their use of methylxanthine
containing substances and drinks. For a literature comparison
and for having a basis about PN drug use, data about the general
knowledge of PN and the use of prescription and illicit substances
were collected, too. However, mainly this preliminary study
wants to open a new chapter of methylxanthines research for PN.
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TABLE 1 | Basic characteristics of the survey participants (n = 683).
Agea M = 26.6 SD = 6.6
Gender Male 187 (27.4%)
Female 496 (72.6%)
Profession Students and trainees 555 (81.3%)
Employees 93 (13.6%)
Double stressb 22 (3.2%)
Others 13 (1.9%)
Mean (M) and standard deviation (SD), or number and percentage of participants
are shown.
aAge in years.
bMeaning students that are also employed.
MATERIALS AND METHODS
The present study was designed as an online survey using
the survey tool “Unipark” and distributed among employees,
students and alumni of the University of Applied Sciences
(UAS) in Neubrandenburg (NB), in Mecklenburg-Vorpommern,
a federal state in north-eastern part of Germany. Announcements
for the survey were distributed via electronic media: homepage,
social media and mailing lists of the above mentioned UAS. The
invitations were posted and mailed in June 2016; the survey was
opened between July and September 2016.
In total 717 participants participated in the survey.
Participants with missing data (n = 34; 4.7%) had to be
excluded. The remaining 683 participants have been included in
the analysis of the survey.
The data was acquired using a self-designed online survey
to ensure a high degree of privacy and anonymity for all
participants. Before the questionnaire starts, participants were
informed about the aim and the content of the questionnaire. A
section explaining the emphasis on caffeine use for PN was given
in bold letters. The chemically correct term “methylxanthine”
was avoided and replaced by the word “caffeine” to make the
emphasis clearer for all participants.
PN was defined in the introduction of the questionnaire to
be the use of divergent substances (drugs and drinks) with the
specific aim to increase cognition (e.g., wakefulness, attention,
concentration, memory) without needing these substance(s) as
a medication because of an existing disease.
Description of the Questionnaire
The questionnaire was built as follows: after questions about
demographic data (sex, age, professional status: student,
employed, student and employee, other), the questionnaire
asked for data about knowledge of PN drugs in general to
build a basis of PN data comparable to the present literature:
having ever heard about those by type of source of knowledge
[print media, TV, internet, colleagues, friends/relatives, (other)
students], type/class of substance: over-the-counter (OTC)
drugs (including caffeine, Ginkgo biloba, etc.), prescription
drugs (methylphenidate, e.g., Ritalin R©) and illicit drugs (illicit
amphetamines e.g., “Speed”); having used substances with the
particular intention of PN and frequency (never, during last
month, during last year, longer than 1 year ago) of the use of (a)
coffee, (b) energy drinks (e.g., Red Bull R©), (c) caffeine pills (e.g.,
Coffeinum R©), (d) caffeine drinks (e.g., Coca Cola R©), (e) black
tea, (f) green tea (g) illicit drugs, and (h) prescription drugs.
The questionnaire then opened a new chapter on the use
of methylxanthine containing substances for PN and asked
the following questions about aspects of using methylxanthine
containing substances: age at first use, motivation/reason for the
use, the subjectively observed/felt neuroenhancing effects, side
effects, the habit of mixing the energy drink with alcohol, average
number of cups of coffee used per day (not for PN purposes). For
each energy drink, participants had the possibility to specify the
brand name.
A pre-test of the questionnaire was conducted among a
dozen of voluntary participants. Based on this pre-test, the
questionnaire was adapted for the survey. Especially the wording
(methylxanthine → caffeine containing, caffeinated → drink
energy drink) was changed to increase understandability for
future participants.
Data Analysis
Data were collected and stored in the Unipark database. Data
were extracted as an Excel file and converted to SPSS (Ver
25.0) which was used for statistical calculations. Variables had
to be (re-) named/characterized according to the variables of
the questionnaire.
Binary univariable logistic regression analyses were used to
predict the use of OTC or illicit and/or prescription drugs,
respectively. As predictor variables age, gender and professional
status were included. For non-normally distributed continuous
variables,Mann-WhitneyU test was applied to test for differences
in the mean between two groups. For two normally distributed
variables a t-test was performed. The association between
categorical variables was assessed by means of Fisher’s exact-test.
For all analyses we consider a p-value of below 0.05 indicating
statistically significant effects. Since our study was designed as
a first, preliminary explorative study, no p-value adjustment for
multiple testing was considered.
In the first part of the questionnaire about PN in general,
single substance names (e.g., methylphenidate, amphetamine,
speed, etc.) were used to simplify the answering process
for all participants. Consistent with the focus of the study
(methylxanthines for PN), substance names were grouped as
follows: Participants who reported using “Speed,” Ritalin R©,
cocaine, Neurodoron R©, ephedrine, amphetamines (including
illicit), prescription drugs for insomnia, ecstasy, MDMA, or
other illicit substances were categorized as those using illicit or
prescription drugs for PN. Prescription and illicit drugs were not
specifically distinguished.
Ethics Statement
The study was performed according to the Declaration of
Helsinki (1975, revised 2000). Participants gave informed consent
by clicking on a button after reading a short introductory
paragraph and by pressing the button “done” at the end of the
survey. This procedure as well as the whole study was approved
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TABLE 2 | General knowledge of pharmacological neuroenhancement according to the type of source where this knowledge came from.
Have you ever heard about
neuroenhancement drugs?








TABLE 3 | Use of OTC an illegal/prescription drugs according to the professional
status (n = 683).
Professional status OTC drugs Illegal/prescription drugs
Employees 89.2% (n = 83) 1.1% (n = 1)
Students 88.1% (n = 489) 2% (n = 11)
“Double-stress” 95.5% (n = 21) 0%
Others 69.2% (n = 9) 0%
by the responsible ethics committee (Neubrandenburg; Approval
No. BB 045/14).
RESULTS
Most of the participants were female (72.6%), with a mean age
of 26.6 years (Table 1). The main group that participated in the
survey were students (81.3%). Further participants were recent
alumni of the same university and were employees, or built a
group of “double-strain” persons (due to their status as students
as well as employees) (see Table 1).
Almost all of the 683 participants (97.7%) had already heard
about the possibility of using substances for PN purposes (see
Table 2). Knowledge about PN substances came from fellow
students (56.5%), TV (56.5%), the internet (54.5%), friends
and family (52.0%), and print media (47.0%). Sharing the
knowledge about PN with colleagues was reported considerably
less often (23.9%).
After the above mentioned general question about
participants’ knowledge of PN, the questionnaire asked explicitly
for the use of methylxanthine containing substances/drinks for
PN (see Table 3).
The vast majority of all participants (88.1%, n = 602, lifetime
prevalence) admitted to have used some of the methylxanthine
containing OTC substances. Only 1.8% of all participants
admitted to use illegal or prescription substances (without
medical prescription). The use of OTC and/or illegal substances
according to the professional status is shown in Table 2. These
results suggest that the rates among employed persons and
students, when it comes to using OTC substances, are equally
high. However, prevalence rates among double stressed (being
student as well as employee) participants were higher (95.5%)
(see Table 3).
No gender differences between the use of methylxanthine
containing OTC substances for PN or the use of illegal or
prescription substances for PN could be found (p = 0.963). The
same applies for the association between professional status and
gender (data not shown).
Regarding the frequency (ever, last year, last month) of using
methylxanthine containing substances/drinks for PN, the most
commonly used substance/drink was coffee (72.9%) followed by
energy drinks 68.2% and cola drinks (62.4%). Methylxanthine
containing tea was used for PN purposes, too: Fifty two
percent of the participants used black tea and 51.7% green
tea. Regarding caffeine tablets, lifetime prevalence was 28.7%
(for further data see Table 4). Only 1.8% of the participants
admitted using illegal substances or substances only available
on prescription (data not shown in the table). The most often
reported illegal/prescription substances were amphetamine type
substances (0.5%). Prevalence rates during “the last 30 days” were
considerably higher than the use of “more than 12 months ago”
and the use “within the last 12 months” which was applicable for
all methylxanthine containing substances/drinks except caffeine
pills. The most frequently used PN substance/drink (49.5%) was
coffee. For more details, please see Table 4.
Binary univariable logistic regression analyses showed that
none of the independent variables (age, gender, professional
status) could predict the use of OTC or illicit and prescription
substances, respectively (data not shown). Regarding the sources
of information of PN and use of OTC substances for PN, only the
category “knowing about it from other students” gained statistical
significance (p < 0.05).
Regarding the brand names of the energy drinks, the most
frequently used energy drink was Red Bull R© (n = 268, 39.2%)
followed by Monster R© (n = 118, 17.3%), Rockstar R© (n = 100,
14.6%) and Relentless R© (n = 68, 10.0%) and further brands that
are less well-known (e.g., Bullit Energy R©, Magic Man R©, Grizzly
Energy R©, Bizz up Energy R©, Black Cat R©, etc.).
Age of first use (mean values, M, ± standard deviation, SD)
were for coffee 16.0 ± 2.9 years and for energy drinks 16.7 ± 3.8
years, for caffeine pills 19.1± 3.5 years, for cola drinks 10.5± 3.3
years, for black tea 14.8 ± 4.9 and for green tea 16.9 ± 5.4 years
(see Table 5).
Asked for specific situations in which methylxanthine
containing substances/drinks were used, the most frequently
named situation was tiredness (n = 305, 44.7%). This aspect
was followed by the items work during nights (n = 251, 36.7%),
examinations and stress associated with examinations (n = 167,
24.5%), stress associated with pressure to perform (in general) (n
= 152, 22.3%), cognitively demanding work (n = 137, 20.1%)
as well as learning (in general) (n = 131, 19.2%), somatic
demanding work (n = 71, 10.4%), time pressure (n = 59, 8.6%),
boredom (n = 46, 6.7%) and a bad mood (in general) (n = 28,
4.1%) (see Figures 1, 2 and Table 6).
According to the above mentioned situations the most
frequently stated aim was the reduction of tiredness (n = 349,
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TABLE 4 | Prevalence rates for the use of legal neuroenhancement substances.
Substance used for
neuroenhancement






Coffee 185 (27.1%) 338 (49.5%) 98 (14.3%) 42 (6.1%)
Energy drinks 217 (31.8%) 216 (31.6%) 120 (17.6%) 93 (13.6%)
Caffeine pills 487 (71.3%) 17 (2.5%) 28 (4.1%) 75 (11.0%)
Cola drinks 257 (37.6%) 227 (33.2%) 107 (15.7%) 52 (7.6%)
Black tea 326 (47.7%) 147 (21.5%) 109 (16.0%) 48 (7.0%)
Green tea 330 (48.3%) 137 (20.1%) 111 (16.3%) 46 (6.7%)
TABLE 5 | Age of first use of methylxanthines for neuroenhancement.
Methylxantine used for neuroenhancement Age of first use
Coffee 16.0 ± 2.9 years
Energy drinks 16.7 ± 3.8 years
Caffeine pills 19.1 ± 3.5 years
Cola drinks 10.5 ± 3.3 years
Black tea 14.8 ± 4.9 years
Green tea 16.9 ± 5.4 years
51.1%). Further frequently stated aims were increase of attention
and concentration (attention: n = 188, 27.5%; concentration: n
= 204, 29.9%), increase of somatic performance and reduction of
stress/pressure to perform (each n= 99, 14.5%) (see Figures 1, 2
and Table 6).
Participants were asked if they had felt an increase
regarding somatic and cognitive performance after having used
a methylxanthine containing substance/drink: 21.2% (n = 145)
had felt an increase of somatic performance and 28.4 (n = 194)
of cognitive performance.
The most common side effects were tachycardia (n = 113,
16.5%), pronounced restlessness (n= 79, 11.6%), sleeplessness (n
= 71, 10.4%), jitteriness (n= 63, 9.2%) and nervousness (n= 65,
9.5%). Infrequent side effects were stomachache (n = 34, 5.0%),
headache (n = 24, 3.5%) as well as nausea and vomiting (n = 19,
2.8%) (see Table 7).
Regarding the question, whether participants had mixed
energy drinks with alcohol, 9.5% (n = 65) stated that they had
never done this, 9.4% (n= 64) during the last 30 days, 18% during
the last year (n = 123) and 20.5% (n = 140) during a period
longer than 1 year ago.
Daily use of coffee varied between one and eight cups (see
Table 8): 35.0% (n = 239) reported to drink one cup per day,
14.9% (n = 102) two cups, 8.2% (n = 56) three cups, 3.5% (n
= 24) four cups, 2.3% (n = 16) five cups, 1.3% (n = 9) six cups,
no one seven cups and 0.3% (n= 2) eight cups.
DISCUSSION
The present study focused on a population of students and recent
alumni from a German university. During this life phase, exams
and first challenges of the new job after graduationmight increase
the desire to enhance the cognitive performance. However,
the decision has to be made whether a legal—which means a
methylxanthine containing substance or drink in most cases—or
an illegal substance (e.g., amphetamine) should be used for PN.
According to higher prevalence rates for caffeinated substances
compared to prescription/illicit substances, this study as well as
previous studies (8, 21, 22, 26) show, that the majority of subjects
tend to the use of a legal substance. This is, in most cases, a
methylxanthine containing substance or drink. Therefore, we
evaluated the use of “soft” neuroenhancement with caffeinated
drinks and substances (caffeine pills) that were used only for the
purpose to stimulate cognition (PN). Not all participants were
willing to fill out the questionnaire about the use of PN substances
and drinks. It could be shown that coffee with a consumption rate
of over 70% was the most widely used drink for PN. The next
most frequently used substances were energy drinks with a level
close to 70%. Taken all caffeinated drinks together, over 88% of
all study participants reported to use these drinks for PN.
The current cognitive enhancement debate about academic
performance is dominated by the misuse of “prescription drugs”
(8). The current study as well as studies from 2011 and 2013
(8, 21) observed low rates for the use of prescription and illicit
substances, while others found higher proportions: A French
study showed that nearly 70% of medicine/pharmacy students
used neuroenhancers within the last 12 month (27). In our
study sample the prevalence rates for the use of illegal drugs
and prescription drugs (use without medical prescription) was
only 1.8%. However, the question for using prescription and/or
illicit drugs for PN in the present study was only asked to
establish a basis to enable a comparison to other studies. Main
focus of this preliminary study was raising data about the use of
methylxanthines for PN leading to the problem, that there are
nearly no similar studies.
The above mentioned lifetime prevalence of 1.8% for
prescription/illicit substances is more or less similar to a previous
German study where students showed a life-time prevalence
for prescription drugs (e.g., amphetamines, methyphenidate)
of 0.8% (last-year and last-month prevalence rates were much
lower). For the use of illicit drugs, a life-time prevalence for
2.9% was reported for this student group (22). This previous
study as well as the present study are in contrast to a study
of Maier et al. (8). In our sample of students and associates
of the university of Neubrandenburg, the use of prescription
substances like methylphenidate was minimal compared to their
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FIGURE 1 | (According to Table 6): Situations of the use of methylxanthines for neuroenhancement.
FIGURE 2 | (According to Table 6): Aims for the use of methylxanthines for neuroenhancement.
results. Reason for these differences might include the rural
area of Neubrandenburg with possibly less opportunities of
getting inappropriate access to drugs on prescription. Another
reason could also be different regulations and laws varying from
Switzerland to Germany and participant’s average age.
In contrast to prescription substances, caffeinated drinks
offer a legal alternative for neuroenhancement and are already
widely used for leisure use. The fact that the vast majority of
students in this study used coffee, green tea (e.g., Club-Mate R©),
energy drinks (e.g., Red Bull R©) and cola drinks to enhance their
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TABLE 6 | Situations and aims for the use of methylxanthines are used for
neuroenhancement.
Situations Aims
Tiredness (n = 305, 44.7%) Reduction of tiredness (n = 349,
51.1%)
Work during nights (n = 251, 36.7%) Increase attention (n = 188, 27.5%)
Stress associated with exam (n =
167, 24.5%)
Increase concentration (n = 204,
29.9%)
Stress associated with pressure to
perform (in general) (n = 152, 22.3%)
Increase of somatic performance (n =
99, 14.5%)
Cognitively demanding work (n =
137, 20.1%)
Reduction of stress/pressure to
perform (n = 99, 14.5%)
Learning (in general) (n = 131, 19.2%)
Somatic demanding work (n = 71,
10.4%)
Time pressure (n = 59, 8.6%)
Boredom (n = 46, 6.7%)
Bad mood (in general) (n = 28, 4.1%)
TABLE 7 | Side effects.
Side effects Participants
Tachykardia 16.5% (n = 113)
Pronounced restless 11.6% (n = 79)
Sleeplessness 10.4% (n = 71)
Jitteriness 9.2% (n = 63)
Nervousness 9.5% (n = 65)
Stomachache 5.0% (n = 34)
Headache 3.5% (n = 24)
Nausea and vomitus 2.8% (n = 19)
TABLE 8 | Daily cups of coffee.
Cups of coffee per day Participants
One cup 35.0% (n = 239)
Two cups 14.9 (n = 102)
Three cups 8.2% (n = 56)
Four cups 3.5% (n = 24)
Five cups 2.3% (n = 16)
Six cups 1.3% (n = 9)
Seven cups /
Eight cups 0.3% (n = 2)
cognitive performance was somehow surprising. This also means
that only a minority of students does not take any substances
for PN.
For the majority of participants in our study, the use
of caffeinated led to side effects such as sleep disturbances.
Caffeinated beverages have been shown to provoke a dose
dependent negative effect on sleep onset, time and quality (28).
This is in line with the data of the “Arzneimittelfachinformation”
according to the regulatory affairs of the EMA (European
Medicine Agency) for caffeine tablets. This is due to the
mechanism of action of caffeine being the same in all
methylxanthine containing substances/drinks (green and black
tea as well as in coffee, energy drinks and caffeine tablets).
In our study, we did not find any significant differences
regarding OTC or illicit/prescription substance use between men
and women, respectively. Previously it has been shown that male
students are more likely to use stimulants to improve cognitive
performance than female students (9, 29). Beyond that, we could
show that only “knowing the experience” of PN from others
was able to predict the own use of these stimulants. This clearly
indicates that peer effects do play a strong role in this cohort of
students and recent alumni.
Motives of caffeine consumption have been evaluated in
detail before: Alertness, mood, social, taste, habit and symptom
management were factors identified. The motive “taste” appeared
highly important among all types of caffeine users (30). This
could mean that the widespread flavor motive is a consequence of
the association of the flavor with the negative reinforcing effects
of caffeine. However, the aspect of “flavor” or “taste” was not
addressed in the questionnaire because of the strong focus on PN.
Regarding the situations in which methylxanthines are used,
the present study shows tiredness, work during nights, stress,
pressure to perform, somatic and cognitively demanding work,
learning and time pressure to be the most prevalent situations.
The aims (reduction of tiredness, increase of attention and
concentration, increase of performance, reduction of stress) are
tightly associated with these situations. This could mean that
methylxanthine use may be an “instrument” to cope with the
above mentioned situations.
Demanding situations being reasons for PN substance use as
well as the above mentioned aims are in line with a previous
study about caffeine use among surgeons (31). The study by
Franke et al. revealed pressure to perform to be a highly relevant
motive for the use of caffeine. These are the same situations in
which prescription and illicit stimulants are used for PN among
surgeons (32). Beyond that, the situations are quite similar among
students regarding the use of caffeine, prescription and illicit
substances for PN purposes (8, 21, 22, 26). This leads to the
assumption that PN drug use of prescription and illicit substances
can be considered as a coping strategy, too (33). Showing
similar situations and aims for the use of methylxanthines for
PN, the concept of coping strategies seem to be applicable for
methylxanthine use (drug and drink) assessed in the present
study. PN by prescription/illicit substances seem to have a similar
basis as PN by methylxanthine substances/drinks. However, a
previous study has shown, that the decision of students to
consider prescription/illicit stimulants or caffeine is mainly based
on a subjective evaluation of medical and legal (as well as ethical)
aspects (17).
Regarding the brand names of the energy drinks, there are no
scientific comparable studies. However, Red Bull R© seems to be
the most widespread and well-known energy drink, at least in
our study.
Beyond that, years ago, the question of a risk of dependence
caused by the use of methylxanthines has been denied (34).
However, in our study energy drinks such as Red Bull R© are used
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together with alcohol. This confirms previous studies showing
this habit to be associated with the aspect of “partying” (35, 36).
However, out study cannot contribute data to the aspect of using
energy drinks with alcohol for partying reasons.
The present study also has some limitations: Firstly, the
study took place at just one university and the sample size
was relatively small. Furthermore, the group of participants was
not completely homogenous (students, alumni, double stressed
being students as well as employees). However, the majority
of the surveyed students stated to belong to the group of
students. Since the survey was spread by social media and
other online platforms, anybody could have participated, not
only students/alumni of the mentioned university. In summary,
our observations cannot be generalized to the whole group of
German students. The present study, even if preliminary, is a
contribution to the field, adding data and new insights to an
underinvestigated field which has to be considered as a strength.
Further studies with preferably more representative data need
to be conducted in the future. Secondly, mental disorders like
depression, insomnia or attention deficit disorder (ADHD) were
not taken into consideration even though these disorders might
alter the use of neurostimulants. Thirdly, beyond the physically
and mentally stimulating effect of methylxanthines, there are two
further aspects of methylxanthines use: (a) a flavoring aspect of
the taste of caffeine and (b) the question of a cultural habit. Even
if the questionnaire stressed the PN aspect, it has to be considered
that some participants may have merged the three aspects in their
mind which may have led to less exact results.
Finally, there is a high prevalence of using OTC substances
such as methylxanthines for PN compared to the use of
prescription/illicit substances. Furthermore, there seem to
be an enormous pressure to perform among students and
alumni. If this pressure persists, a “switch” from the use of
OTC substances to prescription/illicit substances may occur
according to the so called gate-way hypothesis (the use of legal
substances may reduce the obstacle to use prescription/illicit
substances) (19).
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